Strategic Shifts and Chronic Inflammatory Demyelinating...

added blog Wellness

2025-12-19 11:25:59 -

Strategic Shifts and Chronic Inflammatory Demyelinating Polyneuropathy Market Forecast

As we look toward the 2030 horizon, the pharmaceutical sector is bracing for a wave of biological innovations tailored for rare autoimmune neuropathies. The high cost of treatment remains a barrier; however, the entry of biosimilars is expected to disrupt the current pricing architecture, making life-saving therapies more accessible to a broader demographic. Regulatory bodies are also...

0 Comments 0 Shares 4K Views 0 Reviews